Shandong Buchang Pharmaceuticals (603858.SH) donated medicines and cash totaling 37.6621 million yuan.
Stride Pharmaceutical (603858.SH) announced that recently, the company and its wholly-owned subsidiary Shandong Stride Pharmaceutical Sales Co., Ltd...
Shandong Buchang Pharmaceuticals (603858.SH) announced that recently, the company and its wholly-owned subsidiary Shandong Buchang Pharmaceutical Sales Co., Ltd., and its holding subsidiary Liaoning Aoda Pharmaceutical Co., Ltd. signed donation agreements with relevant public welfare organizations, donating a total of 37.6621 million yuan in medicines and cash for conducting public welfare activities.
In addition to this donation, from the date of the last disclosure of external donations (July 4, 2024) to the date of this announcement, the company and its holding subsidiary have cumulatively donated 3.8045 million yuan, including 318,100 yuan in donated medicines and 3.4864 million yuan in cash, mainly donated to public welfare organizations such as the Beijing Tongxin Gongzhu Public Welfare Foundation, the Beijing Union Medical College Foundation, the China Elderly Health Care Association, and the Beijing Liver and Gallbladder Care Public Welfare Fund for public welfare activities.
Related Articles

Q TECH (01478) intends to sell 51% stake of its Indian subsidiary to Dixon, India for a total consideration of 5.53 billion Rupees.

JL Mag Rare-Earth (06680) announces profit growth expectation in the first half of the year, with a net profit attributable to shareholders of 3 billion to 3.35 billion yuan, a year-on-year increase of 151%-180%.

ACESO LIFE SCI (00474) is selling a total of 569 million shares of Huatian International Construction Investment.
Q TECH (01478) intends to sell 51% stake of its Indian subsidiary to Dixon, India for a total consideration of 5.53 billion Rupees.

JL Mag Rare-Earth (06680) announces profit growth expectation in the first half of the year, with a net profit attributable to shareholders of 3 billion to 3.35 billion yuan, a year-on-year increase of 151%-180%.

ACESO LIFE SCI (00474) is selling a total of 569 million shares of Huatian International Construction Investment.

RECOMMEND

Jensen Huang Confirms NVIDIA to Begin H20 Chip Shipments to China
15/07/2025

Manus Exits China Market Amid $500 Million Valuation, Prompting Concerns Over AI Agent Sector Outlook
15/07/2025

Trump to Allocate $70 Billion in AI and Energy Investment, Escalating the Race for Technological Dominance
15/07/2025